Prescription drug · ANDA
Alendronate Sodium NDC 71205-048
Alendronate sodium 70 mg/1 · Tablet · Oral · Proficient Rx LP
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 71205-048-04 | 71205004804 | 1 BLISTER PACK in 1 CARTON (71205-048-04) / 4 TABLET in 1 BLISTER PACKMarketed from Jun 1, 2018 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Alendronate Sodium
- Generic name (nonproprietary)
- alendronate sodium
- Active ingredients
- Alendronate sodium — 70 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- Proficient Rx LP
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 090124
- Marketing start
- Listing expires
- Other FDA classes
- Diphosphonates (Chemical structure)
- Identifiers
- Product ID 71205-048_6db7f218-1343-4b68-b72d-6605f1838e97SPL ID 6db7f218-1343-4b68-b72d-6605f1838e97SPL set ID 6c4d13fb-490c-4ea9-9b04-003c8d8e9f0cRxCUI 904431UNII 2UY4M2U3RAUPC 0371205048044
- Pharmacologic class
- Bisphosphonate
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N471205004804followed by a unit qualifier and the quantityPackage 71205-0048-04. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Alendronate sodium is a bisphosphonate indicated for: • Treatment and prevention of osteoporosis in postmenopausal women. ( 1.1 , 1.2 ) • Treatment to increase bone mass in men with osteoporosis. ( 1.3 ) • Treatment of glucocorticoid-induced osteoporosis. ( 1.4 ) • Treatment of Paget's disease of bone. ( 1.5 ) Limitations of use: Optimal duration of use has not been determined. For patients at low-risk for fracture, consider drug discontinuation after 3 to 5 years of use. ( 1.6 ) 1.1 Treatment of Osteoporosis in Postmenopausal Women Alendronate sodium tablets are indicated for the treatment of osteoporosis in postmenopausal women. In postmenopausal women, alendronate sodium tablets increase …
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 090124
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Alendronate Sodium | Alendronate sodium 70 mg/1 | TabletOral | A-S Medication Solutions | 50090-3126 |
| Alendronate Sodium | Alendronate sodium 35 mg/1 | TabletOral | Aurobindo Pharma Limited | 65862-328 |
| Alendronate Sodium | Alendronate sodium 35 mg/1 | TabletOral | A-S Medication Solutions | 50090-5474 |
| Alendronate Sodium | Alendronate sodium 10 mg/1 | TabletOral | Aurobindo Pharma Limited | 65862-327 |
| Alendronate Sodium | Alendronate sodium 70 mg/1 | TabletOral | Aurobindo Pharma Limited | 65862-329 |
| Alendronate Sodium | Alendronate sodium 70 mg/1 | TabletOral | A-S Medication Solutions | 50090-5677 |
| Alendronate Sodium | Alendronate sodium 70 mg/1 | TabletOral | Rising Pharma Holdings, Inc. | 64980-342 |
| Alendronate Sodium | Alendronate sodium 10 mg/1 | TabletOral | Rising Pharma Holdings, Inc. | 64980-340 |
| Alendronate Sodium | Alendronate sodium 35 mg/1 | TabletOral | Rising Pharma Holdings, Inc. | 64980-341 |
| Alendronate Sodium | Alendronate sodium 70 mg/1 | TabletOral | NorthStar Rx LLC | 16714-633 |
| Alendronate Sodium | Alendronate sodium 10 mg/1 | TabletOral | NorthStar Rx LLC | 16714-631 |
| Alendronate Sodium | Alendronate sodium 35 mg/1 | TabletOral | NorthStar Rx LLC | 16714-632 |